Advertisement

Disease

For doctors, nurses, soldiers, and other responders fighting the Ebola outbreak in West Africa, currently available protective suits are both too hot to wear in the tropics and often a source of contagion when they're being taken off. To make moving and treating patients safer, Johns Hopkins University, along with international health affiliate Jhpiego and other partners, is developing a new anti-contamination suit for health care workers that is both cooler to wear and easier to remove. Read More
Lasers have been used to analyze the bones of sailors who drowned when the Royal Navy warship the Mary Rose sank in 1545. The new non-destructive technique carried out by the Royal National Orthopaedic Hospital in Stanmore, North London, shows that the men suffered from rickets, shedding new light on nutrition in Tudor England. Read More
Though recent research has given hope to the anti-malaria cause, the deadly disease still claims more than half a million lives each year. A study led by researchers at St Jude Children's Research Hospital in Memphis suggests that a certain compound results in the body's immune system treating malaria-infected cells the same way it does aging red blood cells, leading to the parasite becoming undetectable in mice within 48 hours. Read More
Researchers are zeroing in on what looks like an effective treatment for the symptoms of Multiple Sclerosis. Teams from UC Riverside and New York's Rockefeller University have both used the same compound, indazole chloride, to successfully reverse the progression of MS in mice. The drug appears to be able to stimulate the regeneration of the myelin sheath – the nerve pathway coating that is progressively destroyed as MS attacks the nervous system. Read More
Scientists have produced a single dose Ebola vaccine shown to provide primates with long-term protection from the deadly disease. What is most promising about the development is the delivery method, with the vaccine administered through the nose and lungs, mitigating the associated risk of spreading the disease through infected needles. Read More
A clinical trial of a permanent vaccine for hookworm has been completed in Brazil, giving hope for a permanent end to a problem that affects 600 million people worldwide. US-based Sabin Vaccine Institute, which has developed the vaccine has called hookworm "one of the most pervasive neglected tropical diseases (NTD) affecting the world’s poor." Read More
Over the last ten years, a new type of malaria has been on the rise in the forests of Southeast Asia, and experts are turning to new technologies to try and figure out why. By using drones to observe the environment from above, researchers are gaining a new perspective on how changes to the terrain may be impacting local wildlife and causing the spread of the disease. Read More
Dealing with highly infectious diseases like Ebola is often like a logic problem. Disinfecting rooms is hard enough, but what about protective suits? True, they greatly reduce the chances of infection, but getting them off can bring the risk straight back again if the suit isn't decontaminated first. Xenex has created protocols that conform to those of the US Centers for Disease Control and Prevention (CDC) for its a line of robots that use UV lamps that to decontaminate hospital rooms and protective clothing exposed to the Ebola virus. Read More
Gizmag recently caught up with Team Aezon members Krzysztof Sitko and Neil Rens for an in-depth discussion of their finalist entry to the Qualcomm Tricorder XPRIZE. The competition aims to stimulate advances in the field of diagnostic equipment, with the incentive of a US$10 million prize purse. Such technology has the potential to revolutionize the speed and accuracy with which a diagnosis can be made outside of a hospital environment. Read More
While there has been progress made in the fight against Alzheimer's, our understanding of the dispiriting disease remains somewhat limited, with a definitive cure yet to be found. The latest development comes at the hands of researchers from Yale's School of Medicine, who have discovered a new drug compound shown to reverse the effects of Alzheimer's in mice. Read More
Advertisement